Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02241915 · ClinicalTrials.gov registry record · Phase 4
Use of a Microbial Sealant to Reduce Surgical Site Infections.
A Phase 4 study, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT02241915 is a Phase 4 study that has completed, run by University of Southern California. The registered enrollment target is 100 participants.
The verdict
NCT02241915, a Phase 4 study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
Surgical site infections (SSI) are costly complications that may cause significant morbidity and increase the cost of care, particularly in colorectal surgery. Microbial sealants (MS) are a new class of wound barriers aimed at decreasing SSI, however there is only evidence of benefit in clean Class 1 procedures. Based on its success in Class 1 procedures, we hypothesized that a microbial sealant could reduce the rate of SSI by half for clean contaminated colorectal procedures (Class 2).
Interventions
- PROCEDURE Laparoscopic Surgery
- PROCEDURE Open Colorectal Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02241915
The ClinicalTrials.gov registry entry for NCT02241915 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Laparoscopic Surgery is the first listed.
NCT02241915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02241915 about?
NCT02241915 is a clinical study titled "Use of a Microbial Sealant to Reduce Surgical Site Infections.". Surgical site infections (SSI) are costly complications that may cause significant morbidity and increase the cost of care, particularly in colorectal surgery. Microbial sealants (MS) are a new class of wound barriers aimed at decreasing SSI, however there is only evidence of benefit in clean Class ...
What is the current status of trial NCT02241915?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2011-01.
What interventions are being tested in trial NCT02241915?
The interventions under investigation include: Laparoscopic Surgery (PROCEDURE), Open Colorectal Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02241915?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.